Zovestus Global advises and acquires companies and brands.
Our consultants based in UK/Europe and China accelerate business.
Often they are found helping Chinese companies in Europe and European companies in China
They are skilled at start-ups, creating new brands, boosting business development, reducing risk, due diligence reports, timely new product development, finding new customers and channels, facilitating new market entry, and opening-up new international markets.
Its emerging international pharmaceutical and healthcare company acquires control positions in businesses that may have become non-core to the vendor. They may face restructuring or there are benefits from consolidation, internationalisation and other performance improvement opportunities.
Zovestus has the capacity and flexibility to invest from €1m to €75 million into these acquisitions utilising its own capital and leveraging proprietary co-investment partnerships with several leading financial institutions
Recent consulting projects include sourcing and developing new nutraceutical products from Europe for China. Establishing a sales channel in China for an established USA prescription medicine. Developing an internationalisation strategy for a niche UK based generics company. Providing European BD support for a Chinese aesthetics company. Advising PE funds in London, Shanghai and Johannesburg on European specialty pharma. acquisitions.
For Further information
UK Office
Tel: +44 (0)7795 404034